The Peter Doherty Institute for Infection and Immunity has completed a validation study of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit and associated instrumentation and reagents.
Post-market validation of the Beijing Genomics Institute (BGI) SARS-CoV-2 Real Time PCR platform
About this resource
Publication date:
Publication type:
Report
Audience:
General public
Language:
English